Literature DB >> 9459612

An update on interleukin-4 and its receptor.

P Chomarat1, J Banchereau.   

Abstract

Interleukin-4 (IL-4) exhibits many biological and immunoregulatory functions on B lymphocytes, monocytes, dendritic cells and fibroblasts. The IL-4 gene is located on chromosome 5 and displays several cell-specific regulatory sequences in its promoter, which explain its restricted secretion pattern to activated T cells and mast cells. The IL-4 receptor is multimeric and is constituted by at least IL-4Ralpha, a chain common to other cytokine receptors. Two types of IL-4 receptors have been defined: one constituted by the IL-4Ralpha and the gamma(c) chain, and a second constituted by the IL-4Ralpha and the IL-13Ralpha, which is able to transduce both IL-4 and IL-13 signals. Major events of IL-4 transducing signal have now been elucidated and are known to be mediated through JAK/IRS-2 and STAT6 pathways. Numerous studies have also demonstrated the key regulatory role of IL-4 in allergic responses as well as its anti-tumor and anti-inflammatory effects.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9459612

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  19 in total

Review 1.  Interleukin 4 in systemic sclerosis: not just an increase.

Authors:  S P Atamas; B White
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

2.  Identification of p100 as a coactivator for STAT6 that bridges STAT6 with RNA polymerase II.

Authors:  Jie Yang; Saara Aittomäki; Marko Pesu; Kara Carter; Jussi Saarinen; Nisse Kalkkinen; Elliott Kieff; Olli Silvennoinen
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

3.  Effects of common atopy-associated amino acid substitutions in the IL-4 receptor alpha chain on IL-4 induced phenotypes.

Authors:  Izolda Franjkovic; Andre Gessner; Inke König; Karin Kissel; Anette Bohnert; Anne Hartung; Astrid Ohly; Andreas Ziegler; Holger Hackstein; Gregor Bein
Journal:  Immunogenetics       Date:  2005-01-27       Impact factor: 2.846

4.  Interleukin 4 induces the apoptosis of mouse microglial cells by a caspase-dependent mechanism.

Authors:  Javier A Soria; Daniela S Arroyo; Emilia A Gaviglio; Maria C Rodriguez-Galan; Ji Ming Wang; Pablo Iribarren
Journal:  Neurobiol Dis       Date:  2011-05-23       Impact factor: 5.996

Review 5.  B cells responses and cytokine production are regulated by their immune microenvironment.

Authors:  Monica I Vazquez; Jovani Catalan-Dibene; Albert Zlotnik
Journal:  Cytokine       Date:  2015-03-02       Impact factor: 3.861

6.  Interleukin-4 regulation of human monocyte and macrophage interleukin-10 and interleukin-12 production. Role of a functional interleukin-2 receptor gamma-chain.

Authors:  C S Bonder; J J Finlay-Jones; P H Hart
Journal:  Immunology       Date:  1999-04       Impact factor: 7.397

7.  IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion.

Authors:  E Lubberts; L A Joosten; M Chabaud; L van Den Bersselaar; B Oppers; C J Coenen-De Roo; C D Richards; P Miossec; W B van Den Berg
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

8.  Local effect of IL-4 delivery on polyethylene particle induced osteolysis in the murine calvarium.

Authors:  Allison J Rao; Christophe Nich; Lakshmi S Dhulipala; Emmanuel Gibon; Roberto Valladares; Stefan Zwingenberger; R Lane Smith; Stuart B Goodman
Journal:  J Biomed Mater Res A       Date:  2012-12-05       Impact factor: 4.396

9.  Interleukin-4 stimulates proliferation of endometriotic stromal cells.

Authors:  Zhuo OuYang; Yasushi Hirota; Yutaka Osuga; Kahori Hamasaki; Akiko Hasegawa; Toshiki Tajima; Tetsuya Hirata; Kaori Koga; Osamu Yoshino; Miyuki Harada; Yuri Takemura; Emi Nose; Tetsu Yano; Yuji Taketani
Journal:  Am J Pathol       Date:  2008-07-03       Impact factor: 4.307

10.  Systemic reduction of interleukin-4 or interleukin-10 fails to reduce the frequency or severity of experimental cytomegalovirus retinitis in mice with retrovirus-induced immunosuppression.

Authors:  Emily L Blalock; Hsin Chien; Richard D Dix
Journal:  Ophthalmol Eye Dis       Date:  2012-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.